Upcoming Presentations

Previous Invited Talks & Presentations

97. Lyon GJ  (December 2016) Amino-terminal acetylation of proteins - why?. Seminar, Cold Spring Harbor Laboratory In-House Seminar Series, Cold Spring Harbor, NY

96. Lyon GJ  (November 2016) Human Genetics and Rare Diseases. Seminar, Cold Spring Harbor Laboratory In-House Seminar Series, Cold Spring Harbor, NY  In-House Thanksgiving Symposium LYON Nov 2016

95. Lyon GJ (July 2016) The X-Linked Ogden Syndrome Involving NAA10 and the Amino-Terminal Acetylation of Proteins in Human Biology and Disease. Invited Speaker, Gordon Conference on Protein Processing, Trafficking and Secretion, Colby Sawyer College, New Hampshire.

94. Lyon GJ (May 2016) New human genetic syndromes involving transcription, translation, and protein degradation. Invited Speaker, General Biology Seminar. California Institute of Technology, Pasadena, CA.

93. Lyon GJ. (April 2016) New human neurologic and intellectual disability syndromes involving transcription, translation, and protein degradation.  Invited Speaker, Computational Genomics Seminar Series. Icahn School of Medicine at Mount Sinai, NY. (View Presentation Slides1, Presentation Slides2, Presentation Slides3, Presentation Slides4)

92. Lyon GJ. (February 2016) Speaker in Diagnostic Odyssey Session. Utah Rare Disease Symposium, Salt Lake City, UT.

91. Lyon GJ. (February 2016) New human neurologic and intellectual disability syndromes involving transcription, translation, and protein degradation. Invited Speaker, Columbia Child Neurology and Institute of Genomic Medicine, Columbia University, New York, NY

90. Lyon GJ. (January 2016) A rare genetic “transcriptomopathy” syndrome leading to insights into more common neurologic disorders. Invited Speaker Seminar, New York City Wide Human Genetics Meeting 2016, Rockefeller University, New York City, NY.

89. Lyon GJ. (October 2015) A new intellectual disability syndrome. Seminar, Cold Spring Harbor Laboratory In-House Seminar Series, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.

88. Lyon GJ. (October 2015) Variants in TAF1 are associated with a new syndrome with severe intellectual disability and characteristic dysmorphic features. Presentation, The American Society of Human Genetics (ASHG) 2015, Baltimore, MD.

87. Lyon GJ. (September 2015) Variants in TAF1 are associated with a new syndrome with severe intellectual disability and characteristic dysmorphic features. Presentation, 17th International Fragile X and Other Early-Onset Cognitive Disorders Workshop, Strasbourg, France.

86. Lyon GJ. (September 2015) Optimized sequencing leading to new human genetic syndromes involving transcription, translation, and protein degradation. Seminar, Pohang University of Science and Technology  (POSTECH), Pohang, South Korea.

85. Lyon GJ. (September 2015) Optimized sequencing leading to new human genetic syndromes involving transcription, translation, and protein degradation. Presentation, The 24th KOGO Annual Conference 2015 & The 10th Asian Epigenomics Meeting, The Korea Science and Technology Center, Seoul, Korea. 

84. Lyon GJ. (September 2015) Ogden Syndrome and the role of Nα-acetylation in human health and disease. Presentation, 2015 Symposium of National Creative Initiatives Center for Immune and Vascular Cell Network (NCIC-IVCN), Ewha Womans University, Seoul, Korea.

83. Lyon GJ. (June 2015) Genetic Complexity and Neuropsychiatric Disorders. Presentation, Institute of Medical Genetics and Functional Genomics, Hosted by Svetlana Gorokhova, Marseille, France.

82. Lyon GJ. (May 2015) Using next generation sequencing to discover new human genetic syndromes and reveal new biology. Presentation, GTCbio: 5th Next Generation Sequencing Conference, Boston, MA.

81. Lyon GJ. (May 2015) New human genetic syndromes leading to the discovery of new biology. Presentation, Cold Spring Harbor Laboratory: 80th CSHL Symposium on Quantitative Biology – 21st Century Genetics: Genes at Work, Cold Spring Harbor, NY.

80. Lyon GJ. (May 2015) Discovery and genetic characterization of new neuropsychiatric syndromes from family-based studies. Presentation, Cold Spring Harbor Laboratory: The Biology of Genomes Meeting, Cold Spring Harbor, NY.

79.  Lyon GJ. (April 2015 ) Variants in TAF1 are associated with a new syndrome with severe intellectual disability and characteristic dysmorphic features. Presentation,  10th International Meeting on Copy Variants and Genes in Intellectual Disability and Autism, Troina, Italy.

78. Lyon GJ. (March 2015) Variants in TAF1 are associated with a new syndrome with severe intellectual disability and characteristic dysmorphic features. Presentation, Cold Spring Harbor Laboratory: Wiring the Brain, Cold Spring Harbor, NY.

77.  Lyon GJ. (March 2015) Invited Speaker,  Rare Human Diseases as a Window into New Biology. University of Kansas, Lawrence, KS.

76. Lyon GJ. (February 2015). Invited Speaker, Utah’s Inaugural Rare Disease Day Symposium, Salt Lake City, UT.

75.  Lyon GJ. (November 2014). Human Genetics and Orphan Diseases Presentation, Cold Spring Harbor Laboratory In-House Symposium XXVIII, Cold Spring Harbor, NY.

74.  Lyon GJ. (September 2014). Amino-terminal acetylation of proteins: role in human disease and biology. Center for Integrative Proteomics Research at Rutgers University, New Brunswick, NJ.

73.  Lyon GJ. (July 2014). Ogden Syndrome and the Amino-Terminal Acetylation of Proteins.Medical Scientist Training Program (MSTP) 50th Anniversary Symposium, National Institute of General Medical Sciences (NIGMS), NIH Campus, Bethesda, MD. (View Presentation Slides)

72.  Lyon GJ. (June 2014). Genetic Complexity and Neuropsychiatric Disorders. Nurturing Genetics: Reflections on a Century of Scientific and Social Change, an International and Interdisciplinary Symposium, University of Leeds, Leeds, UK. (View Presentation Slides)

71.  Lyon GJ. (June 2014). Clinical genetics of neurodevelopmental disorders. Department of Genetics and Genomic Sciences and the Institute for Genomics and Multiscale Biology at the Mount Sinai Medical Center, New York, NY. (View Presentation Slides)

70.  Lyon GJ. (May 2014). Challenges for Clinical Implementation of Genomic Medicine. Company Visit and Lecture, Ancestry.com, Provo, UT. (View Presentation Slides)

69.  Lyon GJ. (May 2014). Challenges for Clinical Implementation of Genomic Medicine. Lecture Series, New York Genome Center, New York, NY. (View Presentation Slides)   (View Presentation Video)

68.  Lyon GJ. (April 2014). Clinical Genomics of Neuropsychiatric Illnesses. Lecture, UT-Southwestern, Dallas, TX.

67.  Lyon GJ. (March 2014). Amino-terminal acetylation of proteins: role in human disease and biology. CSHL Neuroscience Seminar Series, Cold Spring Harbor, NY.

66.  Lyon GJ. (January 2014). Clinical Genomics of Neuropsychiatric Illnesses. Stony Brook University, Division of Child and Adolescent Psychiatry, Stony Brook, NY. (View Presentation Slides)

65.  Lyon GJ. (January 2014). Deep Brain Stimulation, Psychiatric Genetics, and iPS cell models of disease.Cold Spring Harbor Laboratory In-House Seminar Series, Cold Spring Harbor, NY. (View Presentation Slides)

64.  Lyon GJ. (December 2013). Increasing Accuracy for Exome and Whole Genome Sequencing. Bio-IT World and Cambridge Healthtech Institute’s Inaugural – Clinical Exome Sequencing, Sheraton Lisboa Hotel and Spa, Lisbon, Portugal. (View Presentation Slides)

63.  Lyon GJ. (November 2013). Advancing Precision Medicine through clinical grade whole genome sequencing, return of results and deep brain stimulation. CSHL Personal Genomes and Medical Genomics Meeting, Cold Spring Harbor, NY. (View Presentation Slides)  (View Presentation Video)

62.  Lyon GJ. (November 2013). Advancing Precision Medicine with Genome Interpretation and Deep Brain Stimulation.Stony Brook University, Department of Neuroscience, Stony Brook, NY. (View Presentation)

61.  Lyon GJ. (November 2013). Advancing Precision Medicine. Regeneron, Inc., Tarrytown, NY.

60.  Lyon GJ. (October 2013). Amino-terminal acetylation of proteins: role in human disease and biology. Stony Brook University, Department of Pharmacology, Stony Brook, NY. (View Presentation)

59.  Lyon GJ. (October 2013). Amino-terminal acetylation of proteins by N-terminal acetyltransferases: mechanisms and relevance to human genetic Diseases. Stony Brook University, Department of Chemistry, Stony Brook, NY. (View Presentation)

58.  Lyon GJ. (September 2013). N=1 Human Study in Clinical Neurosciences: Genomic Guided Medicine and Deep Brain Stimulation. Consumer Genetics Conference, Boston, MA. (View Presentation)

57.  Lyon GJ. (September 2013). Childhood-onset neuropsychiatric disorders. Symposium, Fargen Summit, Faroe Genome Project, Faroe Islands. (View Presentation)

56.  Lyon GJ. (June 2013). Toward more accurate variant calling for personal genomes. The Clinical Genome Conference, San Francisco, CA. (View Presentation)

55.  Lyon GJ. (May 2013). Clinical genetics and other aspects of neuropsychiatric disorders. NGS-Translate World Forum, Boston, MA. (View Presentation)

54.  Lyon GJ. (May 2013). Genomics and Ogden Syndrome. N-terminal acetylation Mini-Symposium convened by Thomas Arnesen, Bergen, NO.

53.  Lyon GJ. (May 2013). Clinical genetics and other aspects of neuropsychiatric disorders. The International Behavioural and Neural Genetics Society (IBANGS), Genes, Brain & Behavior 15th Annual Meeting, Leuven, BE. (View Presentation)

52.  Lyon GJ. (March 2013). Controversies in Giving Data Back. Scripps Future of Genomic Medicine Conference VI, La Jolla, CA. (View Presentation)

51.  Lyon GJ. (March 2013). Genetic and Biochemical Analysis of Childhood-Onset Idiopathic Neuropsychiatric Disorders. Graduate Student Annual Retreat, Stony Brook University, Department of Genetics, Stony Brook, NY.

50. Lyon GJ. (February 2013). Genetic and Biochemical Analysis of Childhood-¬Onset Idiopathic Neuropsychiatric Disorders. Weill Cornell Medical College, Institute for Computational Biomedicine and Department of Physiology and Biophysics Seminar Series, New York, NY. (View Presentation)

49.  Lyon GJ. (February 2013). Whole Genome Sequencing Analysis of a severe Idiopathic Intellectual Disability Syndrome. 20th Annual Molecular Psychiatry Conference, Park City, UT. (View Presentation)

47.  Lyon GJ. (December 2012). Challenges of Clinical Implementation of Genomic Medicine.New York Genome Center, New York, NY. (View Presentation)

46.  Lyon GJ. (November 2012). Introduction to Software Considerations for Processing, Analyzing and Interpreting Exome & Genome Sequence Data in Clinical Settings. World Genome Data Analysis Meeting, San Francisco, CA. (View Presentation)

45.  Lyon GJ. (November 2012). Challenges of Clinical Implementation of Genomic Medicine. CSHL In-House Symposium Series, Cold Spring Harbor, NY. (View Presentation)

44.  Lyon GJ. (November 2012). Challenges of Clinical Implementation of Genomic Medicine. Ethics Panel, CSHL Personal Genomes and Medical Genomics Meeting, Cold Spring Harbor, NY. (View Presentation)

43. Lyon GJ. (October 2012). The Implementation of Clinical Genomics: Ethical, Societal and Regulatory Considerations. Consumer Genetics Conference, Boston, MA. (View Presentation)

42.  Lyon GJ. (October 2012). Clinical issues with the return of Exome and Whole Genome Sequencing Results. VA Open Source Electronic Health Record Agent (OSHERA) Summit, Washington, DC, MD.

41.  Lyon GJ. (October 2012). Finding and Analyzing Human Genetic Variation in Neuropsychiatric Disorders. CSHL In-House Seminar Series, Cold Spring Harbor, NY.

40. Lyon GJ. (October 2012). Summary of Efforts to Achieve and Evaluate High-Quality Exomes and Genomes. Bio-IT Europe Pre-Conference Short Courses: Software Considerations for Processing, Analyzing and Interpreting Sequencing Data, Vienna, AT. (View Presentation)

39.  Lyon GJ. (October 2012). Implementation of Variant Calling Algorithms in Clinical Genome Sequencing. Track I: Clinical Genomics: The Road to the Clinic: Applying Genomics in a Clinical Setting, Bio-IT Europe, Vienna, AT. (View Presentation)

38.  Lyon GJ. (September 2012). Clinical Genomics Perspective in Psychiatry. 3rd Annual Child and Adolescent Psychotherapy and Psychopharmacology Conference. Philadelphia, PA.

37.  Lyon GJ. (September 2012). Cellular and proteomic studies supporting the hypothesis that a newly identified X-linked infantile lethal disorder might be caused by decreased amino-terminal acetylation of proteins. ICG-America, Philadelphia, PA. (View Presentation)

36.  Lyon GJ. (September 2012). Finding and Analyzing Human Genetic Variation in Neuropsychiatric Disorders. Stony Brook University, Department of Genetics, Stony Brook, NY.

35.  Lyon GJ. (September 2012). Clinical progress in autism genetics and treatment. Banbury Meeting Autism and CSHL Systems Biology of Autism: From Basic Science to Therapeutic Strategies Meeting, Cold Spring Harbor, NY. (View Presentation)

34.  Lyon GJ. (August 2012). Taking NGS into the clinic. NGx: Next-Generation Sequencing, Providence, RI. (View Presentation)

33.  Lyon GJ. (July 2012). The Implementation of Clinical Genomics: Ethical, Societal and Regulatory Considerations. ELSI Keynote Speaker, HiTSeq Meeting, Satellite of ISMB Meeting, Long Beach, CA. (View Presentation)

32.  Lyon GJ. (June 12-13, 2012). Clinical issues with the return of Next Generation Sequencing Results. The Clinical Genome Conference, San Francisco, CA. (View Presentation)

31.  Lyon GJ. (May 17-19, 2012). Using VAAST and exome sequencing to identify the genetic basis of idiopathic disorders. Genetics & Genomics Online Conference.

30.  Lyon GJ. (April 2012). Using VAAST and exome sequencing to identify the genetic basis of idiopathic disorders. Genomics Research: Next Gen Sequencing, Boston, MA.

29.  Lyon GJ. (April 2012). Exome Sequencing in idiopathic hemolytic anemia. Red Blood Cell Seminar, UMC Utrecht, Utrecht, NL.

28.  Lyon GJ. (February 2012). Returning Research Results from Next-Generation Sequencing and Analysis to Patients with Idiopathic Disorders. Genomic Screening and Diagnosis of Human Disease Conference, Molecular Medicine TriCon, San Francisco, CA.

27.  Lyon GJ. (February 2012). Mendelism in Neuropsychiatric Disorders. 19th Annual Molecular Psychiatry Conference, Park City, UT.

26.  Lyon GJ. (February 2012). Finding and Analyzing Human Genetic Variation in Neuropsychiatric Disorders. Seminar in Clinical Research, Rockefeller University, New York, NY.

25.  Lyon GJ. (January 2012). Neuropsychiatric genetics in the context of prevention and treatment. Phenotype first? Or Genotype first? Maine Medical Center, Portland, ME.

24.  Lyon GJ. (December 2011).Finding and Analyzing Human Genetic Variation in Neuropsychiatric Disorders.Faculty Recruitment Talk, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. (View Presentation)

23.  Lyon GJ. (December 2011). The ABC’s of Genetics:  Where do we go from here? Grand Rounds, CHOP, Department of Child and Adolescent Psychiatry, Philadelphia, PA.

22.  Lyon GJ. (October 2011). Genetic Variation in Human Disease: From Rare Monogenic Disorders to Common Complex Disorders. Research Seminar, Weill Cornell Medical College, Department of Genetic Medicine, New York, NY.

21.  Lyon GJ. (October 2011). Massively parallel sequencing identifies a previously unrecognized X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency. 12th International Congress of Human Genetics (ICHG) and 61st Annual Meeting of the American Society of Human Genetics (ASHG), Montreal, CAN.

20.  Lyon GJ. (October 2011). Using VAAST and exome sequencing to identify the genetic basis of idiopathic disorders. Human Genome Variation Society Meeting, Exome & Genome Analysis as a Tool for Disease Identification & Treatment, Montreal, CAN.

19.  Lyon GJ. (October 2011). Returning Research Results from Next-Generation Sequencing and Analysis to Patients with Idiopathic Disorders? Podium Presentation, CSHL Personal Genomes Meeting, Cold Spring Harbor, NY.

18.  Lyon GJ. (September 2011). Development and Use of VAAST in Mendelian disorders and complex diseases. NGx: Next-Generation Sequencing- Data Management, Providence, RI.

17.  Lyon GJ. (September 2011). Using VAAST to discover the genetic basis of a new disease. Short Course, NGx: Next-Generation Sequencing, Providence, RI.

16.  Lyon GJ. (September 2011). Massively parallel sequencing identifies a previously unrecognized X-linked disorder resulting in lethality in male infants due to amino-terminal acetyltransferase deficiency. Beyond               the Genome, Washington, DC, MD.

15.  Lyon GJ. (September 2010). Genetics and Treatment of Tourette Syndrome, OCD and ADHD. Seminar, University of Washington, Department of Psychiatry, Seattle, WA.

14.  Lyon GJ. (September 2010). Tourette Syndrome, OCD and ADHD – Genetics, Treatment and Pathophysiology. Seminar, University of Pittsburgh, Department of Psychiatry, Translational Neuroscience Seminar Series, Pittsburgh, PA.

13. Lyon GJ. (July 2010). Tourette Syndrome, OCD and ADHD – Genetics, Treatment and Pathophysiology. Seminar, University Neuropsychiatric Institute (UNI), Salt Lake City, UT.

12.  Lyon GJ. (October 2009). “Genetics of Tourette in a Large Pedigree” in Symposium: Update On Tourette’s Disorder: From Research to Practice. 56th American Academy of Child and Adolescent Psychiatry(AACAP), Annual Meeting, Honolulu, HI.

11.  Lyon GJ. (October 2009). Neuropsychiatric genetics. Phenotype first? Or Genotype first? Seminar for Division of Medical Genetics, University of Utah, Salt Lake City, UT.

10. Lyon GJ. (February 20, 2009). Tic Suppression and Executive Function in children with ADHD and Tourette’s Disorder. NYU Child Study Center, NYU Child and Adolescent Psychiatry Grand Rounds, Presentation, New York, NY.

9.  Lyon GJ. (December 2007). 1st AACAP Mentoring Research Retreat, Poster and Oral Presentation on Current and Future Research, Washington DC, MD.

8.  Lyon GJ. (December 2007). Tic suppression with ADHD and Tourette’s Syndrome. 8th Annual Elaine Schlosser Lewis ADHD Research Update Luncheon, Washington DC, MD.

7.  Lyon GJ. (April 2007). Columbia Research Track Resident Seminar Series, Presentation on Current and Future Research, New York, NY.

6.  Lyon GJ, Rodriguez C, Rosell D, Leight K (presenters), Shaffer D, Simpson B, Frankle G (discussants) (January 2006). Neuropsychiatric Case Formulation: A case of severe OCD. Columbia Psychiatry Department Grand Rounds, New York, NY.

5.  Lyon GJ. (February 2002). Rational Design of Global Inhibitors of Virulence in S. aureus. Rockefeller University Pels Seminar, New York, NY.

4.  Lyon GJ. (October 2001). Microbial Pathogenesis Seminar Series, Skirball Institute, NYU, New York, NY.

3.  Lyon GJ. (October 2001). Microbial Pathogenesis and Host Defense Conference, Cold Spring Harbor, NY.

2.  Lyon GJ. (May 2001). Rockefeller University Tri-Lab Seminar Series, New York, NY.

1.   Lyon GJ. (February 2001). Columbia/Rockefeller Chemical Biology Seminar Series, New York, NY.

Previous Conference Posters & Abstracts Presented

70. Malcolmson, J, Fischer, J, and Lyon GJ. (September 2016) The Needs and Expectations of Parents of Children with Rare Conditions that are Undergoing Whole Exome Sequencing (WES). Poster presented by Janet Malcolmson, National Society of Genetic Counselors Annual Education Conference, Seattle, WA.

69. Lyon GJ, Doerfel M, Wu Y, Crain J (July 2016) The X-linked Ogden Syndrome and the amino-terminal acetylation of proteins in human biology and disease. Poster presentation at Gordon Research Conference on Post-Transcriptional Gene Regulation, Stoweflake Resort, Stowe, VT.

68. Wu Y, Klimas A, D’Souza S, Schaniel C, Girnun GC, Entcheva E, Lyon GJ. (May 2016) Protein N-terminal Acetylation is Associated with Cardiac Rhythm Regulation. Heart Rhythm Society’s 37th Annual Scientific Sessions. Heart Rhythm Society. San Francisco, CA. Featured Poster, presentation by Yiyang Wu.

67. Wu Y, Klimas A, D’Souza S, Schaniel C, Girnun GC, Entcheva E, Lyon GJ. (March 2016) Modeling Ogden syndrome in a dish using iPSCs. CiRA/ISSCR International Symposium “Pluripotency: from Basic Science to Therapeutic Application”. Kyoto University. Kyoto. Japan. Poster presentation by Yiyang Wu.

66. Lyon, GJ, (March 2016) A rare genetic “Transcriptomopathy” syndrome leading to insights into more common neurologic disorders. Poster Presentation, Systems Biology: Global Regulation of Gene Expression Meeting, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. (View PDF)

65. Fang H, Doerfel M, Huang Y, Lyon GJ, Schatz MC (February 2016) Scikit-ribo: Accurate A-site prediction and robust modeling of translation control from Riboseq & RNAseq data. Platform presentation by Han Fang, Advances in Genome Biology and Technology(AGBT) Meeting, Orlando, FL.

64. Fang H, Doerfel M, Huang Y, Lyon GJ, Schatz MC. (October 2015) Scikit-ribo: Accurate A-site prediction and robust modeling of translation control from Riboseq and RNAseq data. Platform Presentation by Han Fang at CSHL Genome Informatics Meeting, Cold Spring Harbor, NY.

63. Wu Y, Klimas A, D’Souza S, Schaniel C, Girnun GC, Entcheva E, Lyon GJ. (October 2015) Modeling Ogden syndrome using human induced pluripotent stem cells. NYSCF’s Tenth Annual Translational Stem Cell Conference. The Rockefeller University. New York City. NY. Poster presentation by Yiyang Wu.

62. Fang H, Doerfel M, Huang Y, Lyon GJ, Schatz MC. (October 2015) Scikit-ribo: Accurate A-site prediction and robust modeling of translation control from Riboseq and RNAseq data. Poster Presented by Han Fang at CSHL Meeting Probabilistic Modeling in Genomics, Cold Spring Harbor, NY.

61. Fang H, Grabowska EA, Arora K, Vacic V, Zody M, Iossifov I, O’Rawe JA, Lyon GJ, Wigler M, Schatz MC, Narzisi G. (October 2015) De novo and somatic indel variant analysis of whole genome and exome capture sequencing experiments with Scalpel. Poster Presentation, The American Society of Human Genetics (ASHG) 2015, Baltimore, MD. *2015 Reviewers’ Choice Abstracts

60. Lyon GJ. (August 2015) Variants in TAF1 are associated with a new syndrome with severe intellectual disability and characteristic dysmorphic features. Poster Presentation, Mechanisms of Eukaryotic Transcription Meeting, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.

59. Lyon GJ. (July 2015) Amino-terminal acetylation of proteins in human biology and disease. Poster Presentation, GRC: Molecular Membrane Biology, Proctor Academy, Andover, NH.

58. Lyon GJ. (July 2015) Optimized sequencing leading to new human genetic syndromes involving transcription, translation, and protein degradation. Poster, GRC: Human Genetics and Genomics, State of the Art Human Genome Science: Illuminating Past and Shaping Future Controversies, Newport, RI.

57. Lyon GJ. (April 2015) New human genetic syndromes and optimized next generation sequencing leading to the discovery of new biology. Poster, Wellcome Trust: Genomics of Rare Disease: Beyond the Exome Meeting. Wellcome Trust Genome Campus, Hinxton, UK.

56.  Lyon GJ and Rope A. (March 2015). Comprehensive Whole Genome Sequencing Provides a Possible Etiology for a New Syndrome Characterized by Severe Intellectual Disability and Recognizable Dysmorphic Features. Presentation by Alan Rope, American College of Medical Genetics Meeting, Salt Lake City, UT.

55.  Lyon GJ and O’Rawe J. (November 2014). Large pedigrees in human sequencing studies: toward a more resolved and accurate picture of genetic disease. Poster Presentation by Jason O’Rawe, CSHL In-House Symposium, Cold Spring Harbor, NY.

54.  Lyon GJ and Jimenez-Barron LT. (November 2014). Genome Wide Variant Analysis of families with Autism Spectrum Disorder (ASD) using an Integrative Bioinformatics Pipeline. Poster Presentation by Laura T. Jimenez-Barron, CSHL In-House Symposium, Cold Spring Harbor, NY.

53. Lyon GJ and Fang H. (November 2014). Reducing INDEL calling errors in whole genome and exome sequencing data. Poster Presentation by Han Fang, CSHL In-House Symposium, Cold Spring Harbor, NY.

52. Lyon GJ and Jimenez-Barron LT. (November 2014). Genome Wide Variant Analysis of families with Autism Spectrum Disorder (ASD) using an Integrative Bioinformatics Pipeline. Poster Presentation by Laura T. Jimenez-Barron, CSHL Personal Genomes Meeting, Cold Spring Harbor, NY. (View Presentation Poster)

51. Lyon GJ and Fang H. (November 2014). Reducing INDEL calling errors in whole genome and exome sequencing data. Poster Presentation by Han Fang, CSHL Personal Genomes Meeting, Cold Spring Harbor, NY. (View Poster Presentation)

50. Lyon GJ and Fang H. (November 2014). Whole genome analysis of an extended pedigree with Prader-Willi Syndrome, Hereditary Hemochromatosis, Familial Dysautonomia, Tourette Syndrome and other illnesses.Poster Presentation by Han Fang, CSHL Personal Genomes Meeting, Cold Spring Harbor, NY. (View Presentation Poster)

49. Lyon GJ and O’Rawe J. (November 2014). Large pedigrees in human sequencing studies: toward a more resolved and accurate picture of genetic disease.Poster Presentation by Jason O’Rawe, CSHL Personal Genomes Meeting, Cold Spring Harbor, NY. (View Presentation Poster)

48. Lyon GJ and Fang H. (November 2014). Reducing INDEL calling errors in whole genome and exome sequencing data.Poster Presentation by Han Fang, CSHL Biological Data Science Meeting, Cold Spring Harbor, NY. (View Presentation Slides)

47. Lyon GJ and O’Rawe J. (October 2014). Large pedigrees in human sequencing studies: toward a more resolved and accurate picture of genetic disease. Poster Presentation by Jason O’Rawe, 64th Annual Meeting of the American Society of Human Genetics (ASHG), San Diego, CA. (View Presentation Poster)

46. Lyon GJ and Fang H. (October 2014). Reducing INDEL calling errors in whole-genome and exome sequencing.Poster Presentation by Han Fang, 64th Annual Meeting of the American Society of Human Genetics (ASHG), San Diego, CA. (View Presentation Poster)

45. Lyon GJ and Doerfel M. (October 2014). Molecular and cellular effects of the Ogden Syndrome S37P mutation on the function of the N-terminal acetyltransferase Naa10. Poster Presentation by Max Doerfel, 64th Annual Meeting of the American Society of Human Genetics (ASHG), San Diego, CA. (View Presentation Poster)

44. Lyon GJ and Doerfel M. (September 2014). An X-linked infantile lethal disorder deficient in the pathway for Nα-terminal acetylation of proteins. Poster Presentation by Max Doerfel, CSHL Translational Control Meeting, Cold Spring Harbor, NY.

43. Jimenez-Barron LT. (June 2014). Variant Analysis of Simplex Autism Families. Presentation by Laura T. Jimenez-Barron, CSHL Woodbury Genomics In-House Seminar, Woodbury, NY. (View Presentation Slides)

42. Lyon GJ, Doerfel M. (May 2014). Molecular and cellular effects of the Ogden syndrome S37P mutation on the function of the N-terminal acetyltransferase Naa10. Presentation by Max Doerfel, CSHL Molecular Chaperones & Stress Responses Meeting, Cold Spring Harbor, NY.

41. Lyon GJ, Fang H. (May 2014). Complexities of INDEL detection based on micro-assembly methods: WGS and WES comparisons. Poster Presented by Han Fang, CSHL Biology of Genome Meeting, Cold Spring Harbor, NY.

40.  Wu Y. (April 2014). Ogden Syndrome and iPSC model. Presentation by Yiyang Wu, Stony Brook University Genetics Seminar, Graduate Program, Stony Brook, NY.

40. Fang H. (April 2014). Complexities of INDEL detection based on micro-assembly methods; WGS and WES comparisons. Presentation by Han Fang, CSHL Woodbury Genomics In-House Seminar, Woodbury, NY.

39. Lyon GJ. (April 2014). Whole genome sequencing, clinical interpretation, and deep brain stimulation in a severely mentally ill person.Poster, CSHL Neural Circuits Meeting, Cold Spring Harbor, NY. (View Presentation Poster)

38. Fang H, Wu Y, O’Rawe J, Mittelman D, Lyon GJ. (November 2013). Whole genome sequencing analysis of a family with familial dysautonomia and neuropsychiatric symptoms. Poster, Cold Spring Harbor Laboratory, Precision Medicine Meeting, Cold Spring Harbor, NY. (View Poster Presentation)

37. O’Rawe J, Wu Y, Mittellman D, Fang H, Lyon GJ. (November 2013). Uncovering genetic components of a previously un-described syndrome. Poster, Cold Spring Harbor Laboratory, Precision Medicine Meeting, Cold Spring Harbor, NY. (View Poster Presentation)

36. Lyon GJ. (July 2013). Whole genome sequencing, clinical interpretation, and deep brain stimulation in a severely mentally ill person. Poster, CSHL Wiring the Brain Meeting, Cold Spring Harbor, NY. (View Poster Presentation)

35. Lyon GJ. (July 2013). Whole genome sequencing, clinical interpretation, and deep brain stimulation in a severely mentally ill person. Poster, Gordon Research Conference, Human Genetics and Genomics, Smithfield, RI. (View Poster Presentation)

34. Lyon GJ. (May 2013). Low concordance of variant calling algorithms in exome sequencing. Poster Presented by Jason O’Rawe, CSHL Biology of Genomes Meeting, Cold Spring Harbor, NY. (View Poster Presentation)

33. Lyon GJ. (April 2013).  Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing. Cold Spring Harbor Laboratory, Computational Biology & Bioinformatics Seminar Series, Cold Spring Harbor, NY. (View Presentation)

32. Lyon GJ. (March 2013). Whole Genome Sequencing Analysis of an Idiopathic Mental Retardation Syndrome.Poster Presented by Kai Wang, American College of Medical Genetics (ACMG), Phoenix, AZ. (View Poster Presentation)

31. Lyon GJ. (March 2013). The Implementation of Clinical Genomics: Ethical, Societal and Regulatory Considerations. Poster Presented by Reid Robison, American College of Medical Genetics (ACMG), Phoenix, AZ. (View Poster Presentation)

30. Lyon GJ. (March 2013). Toward more accurate variant calling for “personal genomes.” Post Presented by Kai Wang, American College of Medical Genetics (ACMG), Phoenix, AZ. (View Poster Presentation)

29. Lyon GJ. (February 2013). Toward more accurate variant calling for “personal genomes.” Poster, Advances in Genome Biology and Technology (AGBT) Conference, Marco Island, FL.

28. Lyon GJ. (February 2013). Whole Genome Sequencing Analysis of a severe Idiopathic Intellectual Disability Syndrome. Poster, Gordon Conference on Quantitative Genetics and Genomics, Galveston, TX.

27. Lyon GJ and O’Rawe J. (February 2013). Applications of Whole Genome Sequencing: a familial Analysis of a severe Idiopathic Intellectual Disability Syndrome. Poster Presented by Jason O’Rawe, CSHL From Base Pair to Body Plan Meeting – Celebrating 60 Years of DNA Meeting, Cold Spring Harbor, NY.

26. Guo Y, Lyon GJ, Wang K. (November 2012). Automated pipeline for whole exome/genome  sequencing analysis on Mendelian diseases. Poster Presented by Kai Wang, Annual Meeting of the American Society of Human Genetics, San Francisco, CA.

25. Lyon GJ. (November 2012). Low concordance of variant calling algorithms in exome sequencing Poster, 62nd Annual Meeting of the American Society of Human Genetics, San Francisco, CA.

24. Lyon GJ. (May 2012). The Implementation of Clinical Genomics: Ethical, Societal and Regulatory Considerations. Poster, CSHL Biology of Genomes Meeting, Cold Spring Harbor, NY.

23.  Narzisi G, Iossifov I, Levy D, Lee Y, Wang Z, Pradhan K, Lyon GJ, Wigler M, Schatz MC. (May 2012). Scalpel: Detection and validation of de novo mutations in exome-capture data using micro-assembly. Poster Presented by Giuseppe Narzisi. Cold Spring Harbor Laboratory, Biology of Genomes Meeting, Cold Spring Harbor, NY.

22. Lyon GJ, Van Damme P, Kalvik T, Myklebust L, Gevaert K, Arnesen T. (February 12-16, 2012). Cellular and proteomic studies supporting the hypothesis that a newly identified X-linked infantile lethal disorder might be caused by decreased amino-terminal acetylation of proteins. Chemical Biology and Novel Tools in Pharmacology, Santa Fe, NM.

21. Glessner JT, Hadley D, Wang K, Bradfield J, Kim C, Mentch F, Qiu H, Frackelton E, Li J, Hou C, Otieno FG, Thomas K,  Seidler K, Chiavacci R, Connolly J, Lyon GJ, Tian L, Keating B, Sleiman PMA, Grant SFA, Li M, Hakonarson H. (October 2011). Genome copy number variation landscape in 68,000 humans and relevance to complex disease. Platform Presentation given by Joe Glessner for American Society of Human Genetics Meeting, Montreal, CAN.

20. Lyon GJ. (September 2011). Poster Presentation, XIXth World Congress of Psychiatric Genetics, Washington DC, MD.

19. Lyon GJ, Wang K, Xing J, Swensen JJ, Robison R, Johnson WE, Moore B, Hakonarson H, Reese M, Yandell M. (September 2011). Returning Research Results in the Context of Next-Generation Sequencing for Idiopathic Disorders? CSHL Personal Genomes Meeting, Cold Spring Harbor, NY. (View Presentation)

18. Reese MG, de la Vega F, Chervitz S, Russell A, Kiruluta EE, Huff C, Hu H, Moore B, Jorde L, Lyon GJ, Yandell M. (September 2011). A clinical genome interpretation system: variant prioritization in personal genomes for clinical applications. CSHL Personal Genomes Meeting, Cold Spring Harbor, NY.

17. Lyon GJ. (2011). Massively parallel sequencing identifies a previously unrecognized X-linked disorder resulting in lethality in male infants owing to amino-terminal acetyltransferase deficiency. Genome Biology, Volume 12, Supplement 1, P13, DOI: 10.1186/1465-6906-12-S1-P13. Beyond the Genome.

16. Lyon GJ. (August 2011). Drug Discovery and Diagnostic Development Week, Next Generation Sequencing and Genomic Medicine, San Francisco, CA.

15. Lyon GJ. (July 2011). Using VAAST and Next Gen Sequencing to characterize a novel disorder caused by protein N-terminal acetyltransferase Deficiency. Gordon Research Conference, Human Genetics and Genomics, Newport, RI.

14. Lyon GJ. (May 2011). Massively parallel sequencing and clinical characterization of a novel disorder caused by protein N-terminal acetyltransferase deficiency. CSHL Biology of Genomes Meeting, Cold Spring Harbor, NY.

13. Yandell M, Huff C, Hu H, Singleton M, Moore B, Xing J, Jorde L, Kronenberg Z, Chervitz SA, Lyon GJ, Reese MG. (May 2011). A Probabilistic disease gene finder for personal genomes. Platform Presentation and Poster by Mark Yandell at CSHL Biology of Genomes Meeting, Cold Spring Harbor, NY.

12. Hakonarson H, Glessner JT, Wang K, Takahashi N, Shtir CJ, Sleiman PMA, Zhang H, Kim CE, Lyon GJ, Flory JH, Bradfield JP, Imielinski M, Hou C, Frackelton EC, Middleton F, Todorov AA, Reif A, Franke B, Lesch KP, Anney R, Shaw P, Devoto M, Grant SFA, White P, Buxbaum JD,  Rapoport JL, Williams NM, Nelson SF, Faraone SV, Elia J. (November 2010). Genome Wide Copy Number Variation Study Associates Metabotropic Glutamate Receptor Genes with Attention Deficit Hyperactivity Disorder. ADHD GWAS Consortium. Platform Presentation given by Joe Glessner for American Society of Human Genetics Meeting, Washington DC, MD.

11. Lyon GJ. (June 2010). Improving Tic Suppression: Comparing the Effects of Dexmethylphenidate to No Medication in Children and Adolescents with ADHD and Chronic Tic Disorders. NCDEU 50th Anniversary Meeting, Boca Raton, FL.

10. Lyon GJ, Coffey B, Castellanos XF, Woods D, Conelea C, Samar S, Bauer C, Brandt BC, Kemp JK, Lipinski CM, Trujillo MR, Lawrence ZE. (June 2010). Update to Improving Tic-Related Response  Inhibition: Comparing the Effects of Dexmethylphenidate to No Medication in Children and Adolescents with ADHD and Chronic Tic Disorders. NCDEU 50th Anniversary Meeting, Boca Raton, FL.

9. Robison R, Wang K, Hobbs M, Cannon D, Lyon GJ, Miller J, Tuya S, Matsunami N, Leppert M, Hakonarson H, Davis L, Cook E, Facelli J, McMahon W, Coon H. (April 11-15, 2010). Genome-wide analysis of copy number variation in extended autism pedigrees. Towards Defining the Pathophysiology of Autistic Behavior, Sponsored by Simons Foundation, Organizers: Pat Levitt and Joseph Piven, Snowbird Resort, Snowbird, UT.

8. Lyon GJ, Coffey B, Castellanos XF, Woods D, Conelea C, Samar S, Bauer C, Brandt BC, Kemp JK, Lipinski CM, Trujillo MR, Lawrence ZE. (October 2009). Improving Tic-Related Response Inhibition: Comparing the Effects of Dexmethylphenidate to No Medication in Children and Adolescents with ADHD and Chronic Tic Disorders. AACAP 56th Annual Meeting, Honolulu, HI.

7.  Coffey BJ, Jummani R, Hirsch S, Lyon GJ, Spirgel A, Goldman R, Samar S. (October 2008). Aripiprazole in children and adolescents with Tourette’s Disorder: An open label safety and tolerability study. AACAP 55th Annual Meeting, Chicago, IL.

6. Lyon GJ, Coffey B, Castellanos XF, Woods D. (July 2008). Pilot study plan for Improving tic-related response inhibition: Comparing the effects of dexmethylphenidate to placebo in children and adolescents with ADHD and chronic tic disorders. International Journal of Neuropsychopharmacology, Vol 11, Supplement 1, p. 292. CINP Biennial International Congress Meeting, Munich, DE.

5. Lyon GJ. (July 2008). Pilot study plan for “Improving tic-related response inhibition: Comparing the effects of dexmethylphenidate to placebo in children and adolescents with ADHD and chronictic disorders.” 50th Anniversary and XXVI Congress of the CINP (Collegium Internationale Neuro Psychopharmacologicum), Munich, DE.

4. Lyon GJ. (July 2002). Poster, Enzymology Gordon Research Conference, Kimball Union, NH.

3. Lyon GJ. (May 2002). Poster, Yale Chemical Biology Symposium, New Haven, CT.

2. Lyon GJ. (August 2001). Poster, Staphylococcal Diseases Gordon Conference, Bristol, RI.

1. Lyon GJ. (June 2001). Poster, Bioorganic Chemistry Gordon Conference, Proctor, NH.